Kezar Life Sciences, Inc. (KZR)
6.30
-0.05
(-0.79%)
USD |
NASDAQ |
Dec 11, 16:00
6.03
-0.27
(-4.29%)
Pre-Market: 08:07
Kezar Life Sciences EPS Diluted (Quarterly): -1.533 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Artiva Biotherapeutics, Inc. | -0.8794 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.23M |
| Total Expenses (Quarterly) | 11.23M |
| Enterprise Value | -34.17M |
| Earnings Yield | -134.0% |
| Normalized Earnings Yield | -134.04 |